2Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science . 2005
3Kralisch S,Klein J,Lossner U,et al.Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. Journal of Endocrinology, The . 2005
4Winkler G,Cseh K.Molecular mechanisms of insulin resistance in obesity and type 2 diabetes mellitus. Orvosi Hetilap . 2009
5Zhong M,Tan HW,Gong HP, et al.Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clinical Endocrinology . 2008
6Kolsgaard ML,Wangensteen T,Brunborg C, et al.Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome. Scandinavian Journal of Clinical and Laboratory Investigation . 2009
2Alghasham AA, Barakat YA. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy[J]. Saudi Med J ,2008,29(2) : 185 - 92.
3Stringer DM, Sellers EA, Burr LL, et al. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus[J]. Pediatr Diabetes, 2009,10 (4) : 269 - 77.
4Sethi JK, Vidal - Puig A. Visfatin: the missing link between intraab- dominal obesity and diabetes[J]. Trends Mol Med,2005,11(8) :344 - 347.
5Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre - B cell colony - enhancing factor in patients with type 2 diabetes mellitus[J ]. J Clin Endocrinol Metab, 2006,91 (1) : 295 - 299.
6Bemdt J, Klotlng N, Kralishch S, et al. Plasma visfatin concentrations and fat depot - specific mRNA expression in humans [ J ]. Diabetes, 2005,54(10) :2911 - 2916.
7Stofkova A . Leptin and adiponectin., from energy and metabolic dysbalance to inflammation and autoirnmtmity [J ]. Endocr Regul, 2009, 43 (4) : 157 - 68.
8Reinehr T, Kleber M, de Sousa G, et al. Leptin concentrations are a predictor of overweight reduction in a lifestyle intervention [ J ]. Int J Pediatr Obes, 2009,4(4) :215 - 223.
9Li L, Yang G, Li Q, et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects [ J ]. Exp Clin Endocrinol Diabetes, 2006, 114(10) :544 - 8.
10Zhu J, Schott M, Liu R, et al. Intensive glycemie control lowers plasma visfatin levels in patients with type 2 diabetes [J ]. Horm Metab Res, 2008,40( 11 ) : 801 - 5.
2Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin(J).Science,2005;307:426.
3Shepard CW, Finelli L, Fiore AE, et al. Epidemiology of hep- atitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J, 2005, 24(3): 755z760.
4Dai CY, Huang JF, Hsieh MY, et al. Links between triglyceride levels of hepatitis C virus infection and diabetes. Gut, 2007; 56 (4): 1167-1168.
5Meerarani P, Badimon J, Zias E, et al. Metabolic syndrome and diabetic atherothrombosis: implications in vascular corn-plica- tions. Curr Mol Med, 2006, 6(5): 498-501.
6Sonoli SS, Shivprasad S, Prasad CV, et al. Visfatin: a review, Eur Rev Med Pharmacol Sci, 2011, 15(1): 9-14.
7Moschen AR, Gemer RR, Tilg H. Pre-B cell colony enhancing fctor/ INAMPT/visfatin in inflammation and obesity-related disorders [J]. Curt Pharm Des,2010,16( 17): 1913-1920.
8Berndt J, Kloting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans [Jl.Diabetes, 2005,54 ( 10 ) :2911-2916, 2005.
9Esteghamati A, Alamdari A, Zandieh A, et al. Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity[J ].Diabetes Res Clin Pract, 2011,91 (2):154- 158.
10Kang YS, Soung HK, Lee MH, et al. Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabets [J]. Diabetes Res Clin Pratt, 2010,89(2):141-149.
